What’s New with Innocoll?
Catch up on the latest developments.
Innocoll Announces Strategic Investment from Hillhouse Investment
Innocoll Announces Publication of Positive Results from Pivotal Clinical Trial of POSIMIR in Arthroscopic Subacromial Decompression
Innocoll Announces Positive Topline Results for XARACOLL® (bupivacaine hydrochloride) Implant in a Phase 3 Study to Support Expanded Use
Innocoll Announces Co-Promotion Agreement for Hernia Product Portfolio
Innocoll Announces Successful Completion of Debt Refinancing